MSD are proud to have been involved with vaccines for more than a century helping to prevent and control numerous infections.

         

*ZOSTAVAX is the Shingles vaccine used as part of the Shingles National Immunisation Programme
**GARDASIL is the HPV vaccine used as part of the HPV National Immunisation Programme

Supporting documentation

GARDASIL^® (Human Papillomavirus Vaccine [Type 6,11,16,18]) (Recombinant, adsorbed)
Prescribing Information | Patient Information Leaflet | Summary of Product Characteristics

GARDASIL^® 9^▼ (Human Papillomavirus 9 Valent Vaccine) (Recombinant, adsorbed)
Prescribing Information | Patient Information Leaflet | Summary of Product Characteristics

HBVAXPRO^® (hepatitis B vaccine rDNA)

   5mcg
   Prescribing Information | Patient Information Leaflet | Summary of Product Characteristics

   10mcg
   Prescribing Information | Patient Information Leaflet | Summary of Product Characteristics

   40mcg
   Prescribing Information | Patient Information Leaflet | Summary of Product Characteristics

M-M-RVAXPRO^® (measles, mumps and rubella vaccine live)
Prescribing Information | Patient Information Leaflet | Summary of Product Characteristics

PNEUMOCOCCAL POLYSACCHARIDE VACCINE (solution for injection in a vial)
Prescribing Information | Patient Information Leaflet | Summary of Product Characteristics

PNEUMOVAX^® 23 (Pneumococcal Polysaccharide Vaccine solution for injection in a pre-filled syringe)
Prescribing Information | Patient Information Leaflet | Summary of Product Characteristics

VAQTA^® Adult (hepatitis A Vaccine, inactivated, adsorbed)
Prescribing Information | Patient Information Leaflet | Summary of Product Characteristics

VAQTA^® Paediatric (hepatitis A Vaccine, inactivated, adsorbed)
Prescribing Information | Patient Information Leaflet | Summary of Product Characteristics

VARIVAX^® (varicella virus vaccine live [Oka/Merck])
Prescribing Information | Patient Information Leaflet | Summary of Product Characteristics

ZOSTAVAX^® (shingles (herpes zoster) vaccine live)
Prescribing Information | Patient Information Leaflet | Summary of Product Characteristics

GB-CIN-00049 | Date of Preparation: March 2019